CBD is not considered safe during breastfeeding. No major medical organization supports its use while nursing, and the FDA strongly advises against using any cannabis-derived product, including CBD, during this period. The core problem is a lack of safety data: no studies have established what a safe dose looks like for a breastfeeding infant, and the limited research available raises several concerns.
How CBD Gets Into Breast Milk
CBD is fat-soluble, which matters because breast milk is rich in fat. Research published in Frontiers in Pharmacology found that CBD concentrations in breast milk were at least two times higher than in the mother’s blood plasma. That means breast milk doesn’t just carry trace amounts; it actually concentrates the compound. For comparison, only about 0.2% of a maternal THC dose appears in milk, but even that small fraction is enough to raise concern for a developing infant.
CBD also lingers in the body for a long time. Its elimination half-life is estimated at 18 to 32 hours, meaning it can take several days for a single dose to fully clear your system. There’s no reliable “pump and dump” window that would let you time a dose around feedings.
Why Infant Exposure Is Concerning
Newborns and young infants have an active endocannabinoid system that plays a role in brain development, nervous system wiring, and organ growth. This system uses its own naturally produced signaling molecules to guide development during the earliest stages of life. Introducing an outside compound like CBD that interacts with the same system could theoretically disrupt those processes, though the exact effects in breastfed infants haven’t been studied directly.
What we do know comes from clinical trials of the one FDA-approved CBD drug (used to treat severe seizure disorders in children). Those trials identified real risks including liver damage, extreme drowsiness, and harmful interactions with other medications. These effects were observed at pharmaceutical-grade doses in older children, not newborns, but they illustrate that CBD is pharmacologically active and not as gentle as marketing often suggests. An infant’s liver and metabolic systems are far less mature, making them potentially more vulnerable to these effects.
Contamination in CBD Products
Beyond CBD itself, the products on the market carry their own risks. A large analysis of 202 commercially available CBD products found contamination was widespread. Lead was detected in 42 products, with 3% exceeding regulatory safety thresholds. Arsenic showed up in six samples, cadmium in four. Residual solvents from the extraction process were found across 181 of the 202 products tested. And 30 products contained pesticides, mostly fungicides used during hemp cultivation.
The FDA has only approved one prescription CBD product and has not evaluated or approved any over-the-counter CBD supplements, oils, or edibles. That means there are no federal standards ensuring that a CBD tincture or gummy contains what the label claims, is free of contaminants, or is manufactured consistently. For a breastfeeding parent, this unregulated landscape adds a layer of risk on top of the pharmacological concerns. You’re not just exposing your infant to CBD; you’re potentially exposing them to heavy metals, solvents, and pesticides at a stage when their bodies are least equipped to handle them.
What Medical Organizations Recommend
The American College of Obstetricians and Gynecologists states that there are no medical indications for cannabis use during pregnancy or the postpartum period and recommends that providers educate patients about the risks. The FDA’s position is equally direct: it “strongly advises against” the use of CBD or THC in any form during pregnancy or breastfeeding. Both organizations point to the same fundamental gap: we simply don’t have enough data to determine what’s safe for a nursing infant.
It’s also worth knowing that in some jurisdictions, positive screens for cannabinoids can trigger involvement from child protective services, regardless of whether the product was legal to purchase. ACOG specifically flags this as something patients and providers should be aware of.
If You’re Using CBD for a Specific Symptom
Many people turn to CBD for anxiety, pain, or sleep problems, all of which can intensify during the postpartum period. If you’re dealing with any of these, there are alternatives with established safety profiles during breastfeeding. Talking to your provider about what you’re trying to manage is a more productive path than navigating an unregulated supplement market while nursing. The risk with CBD isn’t that a single dose will necessarily cause harm. It’s that no one can tell you it won’t, and the early evidence gives real reasons for caution.